Skip to main content
SpringerLink
Log in

Pathophysiology of variceal bleeding

  • Conference paper
Portal Hypertension in the 21st Century

Abstract

Variceal formation is an almost unavoidable complication of cirrhosis. Varices are already present in about 40% of compensated, asymptomatic patients at diagnosis, and the incidence increases to up to 90% of patients on long-term follow up1. The annual incidence is around 6% per year2.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. D’Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 1999;19:475–505.

    Article  PubMed  Google Scholar 

  2. Pagliaro L, D’Amico G, Pasta L et al. Portal hypertension in cirrhosis: natural history. In: Bosch J, Groszmann RJ, editors. Portal Hypertension: Pathophysiology and Treatment. Oxford: Blackwell Science, 1992:72–92.

    Google Scholar 

  3. Vianna A. Anatomy of the portal venous system in portal hypertension. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, editors. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, 1991:393–9.

    Google Scholar 

  4. Noda T. Angioarchitectural study of esophageal varices (with special reference to variceal rupture). Virchows Arch A. 1984;404:381–92.

    Article  CAS  Google Scholar 

  5. Spence RAJ. The venous anatomy of the lower esophagus in normal subjects and in patients with varices: an image analysis study. Br J Surg. 1984;71:739–44.

    Article  PubMed  CAS  Google Scholar 

  6. Fernandez M, Vizzutti F, Garcia-Pagan JC et al. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology. 2004;126:886–94.

    Article  PubMed  CAS  Google Scholar 

  7. Vorobioff J, Bredfeldt JE, Groszmann RJ. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology. 1984;87:1120–6.

    PubMed  CAS  Google Scholar 

  8. Gupta TK, Toruner M, Chung MK, Groszmann RJ. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology. 1988;28:926–31.

    Article  Google Scholar 

  9. Rockey DC, Chung JJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology. 1998;114:344–51.

    Article  PubMed  CAS  Google Scholar 

  10. Viallet A, Marleau D, Huet PM et al. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology. 1975;69:1297–300.

    PubMed  CAS  Google Scholar 

  11. Garc ía-Tsao G, Groszmann RJ, Fisher RI et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985;5:419–24.

    Article  Google Scholar 

  12. Rigau J, Bosch J, Bordas JM et al. Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. Gastroenterology. 1989;96: 873–80.

    PubMed  CAS  Google Scholar 

  13. Polio J, Groszmann RJ. Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Semin Liver Dis. 1986; 6:318–31.

    Article  PubMed  CAS  Google Scholar 

  14. Groszmann RJ, Bosch J, Grace N et al. Hemodynamic events in a prospective randomized trial of propranolol vs placebo in the prevention of the first variceal hemorrhage. Gastroenterology. 1990;99:1401–7.

    PubMed  CAS  Google Scholar 

  15. Feu F, García-Pagán JC, Bosch J et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal hemorrhage in patients with cirrhosis. Lancet. 1995;346:1056–9.

    Article  PubMed  CAS  Google Scholar 

  16. Casado M, Bosch J, García-Pagán JC et al. Clinical events following TIPS: correlation with hemodynamic findings. Gastroenterology. 1998;114:1296–303.

    Article  PubMed  CAS  Google Scholar 

  17. Villanueva C, Balanzó J, Novella MT et al. Nadolol plus isosorbide-5-mononitrate compared to sclerotherapy for the prevention of variceal rebleeding. N Engl J Med. 1996;334:1624–34.

    Article  PubMed  CAS  Google Scholar 

  18. Villanueva C, Minana J, Ortiz J et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med. 2001;345:647–55.

    Article  PubMed  CAS  Google Scholar 

  19. Vorobioff J, Groszmann RJ, Picabea E et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology. 1996;111:701–9.

    Article  PubMed  CAS  Google Scholar 

  20. Escorsell A, Bordas JM, Castañeda B et al. Predictive value of the variceal pressure response to continued pharmacogical therapy in patients with cirrhosis and portal hypertension. Hepatology. 2000;31:1061–7.

    Article  PubMed  CAS  Google Scholar 

  21. Moitinho E, Escorsell A, Bandi JC et al. Prognostic value of early measurements of portal pressure in acute variceal hemorrhage. Gastroenterology. 1999;117:626–31.

    Article  PubMed  CAS  Google Scholar 

  22. McCormick PA, Dick R, Graffeo M et al. The effect of non-protein liquid meals on the hepatic venous pressure gradient in patients with cirrhosis. J Hepatol. 1990;11:221–5.

    Article  PubMed  CAS  Google Scholar 

  23. Luca A, García-Pagán JC, Bosch J et al. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology. 1997;112:1291–6.

    Article  Google Scholar 

  24. García-Pagán JC, Feu F, Castells A et al. Circadian variations of portal pressure and variceal hemorrhage in patients with cirrhosis. Hepatology. 1994;19:595–601.

    Article  PubMed  Google Scholar 

  25. García-Pagán JC, Santos C, Barbera JA et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology. 1996;111:1300–6.

    Article  PubMed  Google Scholar 

  26. Escorsell A, Ginès A, Llach J et al. Increasing intra-abdominal pressure increases pressure, volume and wall tension in esophageal varices. Hepatology. 2002;36:936–40.

    PubMed  Google Scholar 

  27. Bredfeldt JE, Bosch J, Groszmann RJ. Splanchnic angiography increases portal pressure in portal-hypertensive patients. Hepatology. 1982;2:684 (abstract).

    Google Scholar 

  28. Bosch J, Groszmann RJ. Measurement of azygos venous blood flow by a continuous thermodilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis. Hepatology. 1984;4:424–9.

    Article  PubMed  CAS  Google Scholar 

  29. Bosch J, Mastai R, Kravetz D et al. Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis: clinical and hemodynamic correlations in 100 patients. J Hepatol. 1985;1:125–39.

    Article  PubMed  CAS  Google Scholar 

  30. Kroeger RJ, Groszmann RJ. Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model. Hepatology. 1985;5:97–101.

    Article  PubMed  CAS  Google Scholar 

  31. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol. 1985;248:G618–25.

    PubMed  CAS  Google Scholar 

  32. Mosca P, Lee FY, Kaumann AI, Groszmann RJ. Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium. Am J Physiol. 1992;263:G544–50.

    PubMed  CAS  Google Scholar 

  33. Moreno L, Martínez-Cuesta MA, Piqué JM et al. Anatomical differences in responsiveness to vasoconstrictors in the mesenteric vein from normal and portal-hypertensive rats. Naunyn-Schmiedeberg’s Arch Pharmacol. 1996;354:474–80.

    Article  CAS  Google Scholar 

  34. Lee FY, Albillos A, Colombato LA, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology. 1992;16: 1043–8.

    Article  PubMed  CAS  Google Scholar 

  35. Pizcueta MP, de Lacy AM, Kravetz D et al. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats. Hepatology. 1989;10:953–7.

    Article  PubMed  CAS  Google Scholar 

  36. Escorsell A, Ferayorni L, Bosch J et al. The portal pressure response to beta-blockade is greater in cirrhotic patients without varices than in those with varices. Gastroenterology. 1997;112:2012–16.

    Article  PubMed  CAS  Google Scholar 

  37. Groszmann RJ, García-Tsao G, Makuch R et al. Multicenter randomized placebo-controlled trial of non-selective beta-blockers in prevention of the complications of portal hypertension: final results and identification of a predictive factor. Hepatology. 2003;38 (Suppl. 1):206A.

    Article  Google Scholar 

  38. Feu F, Bordas JM, Luca A et al. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis. Hepatology. 1993;18:1082–9.

    PubMed  CAS  Google Scholar 

  39. Ruiz del Árbol L, Martín de Argila C, Vázquez M et al. Endoscopic measurement of variceal pressure during hemorrhage from esophageal varices. Hepatology. 1992;16:147 (abstract).

    Google Scholar 

  40. Nevens F, Fevery J. Variceal pressure predicts a first variceal hemorrhage: a prospective cohort study. Hepatology. 1996;24:209 (abstract).

    Article  Google Scholar 

  41. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med. 1988;13:983–9.

    Google Scholar 

  42. Lebrec D, De Fleuny P, Rueff B et al. Portal hypertension, size of the varices and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology. 1980;79:1139–44.

    PubMed  CAS  Google Scholar 

  43. Zoli M, Merkel C, Magalotti D et al. Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis. Hepatology. 1996;24:1047–52.

    Article  PubMed  CAS  Google Scholar 

  44. Nevens F, Sprengers D, Feu F et al. Measurement of variceal pressure with an endoscopic pressure sensitive gauge: validation and effect of propranolol therapy in chronic conditions. J Hepatol. 1996;24:66–73.

    Article  PubMed  CAS  Google Scholar 

  45. Miller L, Banson FL, Bazir K et al. Risk of esophageal variceal bleeding based on endoscopic ultrasound evaluation of the sum of esophageal variceal cross-sectional surface area. Am J Gastroenterol. 2003;98:454–9.

    Article  PubMed  Google Scholar 

  46. Escorsell A, Bordas JM, Feu F et al. Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy. Gastroenterology. 1997;113:1640–6.

    Article  PubMed  CAS  Google Scholar 

  47. Genecin P, Polio J, Groszmann RJ. Na restriction blunts expansion of plasma volume and ameliorates hyperdynamic circulation in portal hypertension. Am J Physiol. 1990;259: G498–503.

    PubMed  CAS  Google Scholar 

  48. Garcia-Pagán JC, Salmerón JM, Feu F et al. Effects of low sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis. Hepatology. 1994;19:1095–9.

    PubMed  Google Scholar 

  49. Kravetz D, Bosch J, Arderiu M et al. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting. Hepatology. 1989;9:808–14.

    Article  PubMed  CAS  Google Scholar 

  50. Castañeda B, Morales J, Lionetti R et al. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats. Hepatology. 2001;33:821–5.

    Article  PubMed  Google Scholar 

  51. McCormack TT, Rose JD, Smith PM, Johnson AG. Perforating veins and blood flow in esophageal varices. Lancet. 1983;2:1442–4.

    Article  PubMed  CAS  Google Scholar 

  52. Mastai R, Grande L, Bosch J et al. Effects of metociopramide and domperidone on azygos venous blood flow in patients with cirrhosis and portal hypertension. Hepatology. 1986;6:1244–7.

    Article  PubMed  CAS  Google Scholar 

  53. Saraya A, Sarin SK. Effects of intravenous nitroglycerin and metociopramide on intravariceal pressure: a double-blind, randomized study. Am J Gastroenterol. 1993;88:1850–3.

    PubMed  CAS  Google Scholar 

  54. Casadevall M, Pique JM, Cirera I et al. Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation. Gastroenterology. 1996;110:1156–65.

    Article  PubMed  CAS  Google Scholar 

  55. Bernstein DE, Jeffers L, Erhardtsen E et al. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology. 1997;113:1930–7.

    Article  PubMed  CAS  Google Scholar 

  56. Ejlersen E, Melsen T, Ingerslev J et al. Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol. 2001;36:1081–5.

    Article  PubMed  CAS  Google Scholar 

  57. Thabut D, de Franchis R, Bendtsen F et al. Efficacy of activated recombinant factor VII (rFVIIa; Novoseven) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial. J Hepatol. 2003;38(Suppl. 2):13A.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hepatic Hemodynamic Laboratory, Liver Unit Hospital Clinic, Villaroel 170, 08036, Barcelona, Spain

    Jaime Bosch

Authors
  1. Angels Escorsell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaime Bosch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Yale University School of Medicine, New Haven, CT, USA

    R. J. Groszmann

  2. Hepatic Hemodynamic Laboratory Liver Unit, Hospital Clinic, University of Barcelona, Spain

    J. Bosch

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media Dordrecht

About this paper

Cite this paper

Escorsell, A., Bosch, J. (2004). Pathophysiology of variceal bleeding. In: Groszmann, R.J., Bosch, J. (eds) Portal Hypertension in the 21st Century. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1042-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-1042-9_18

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-3774-7

  • Online ISBN: 978-94-007-1042-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation